バイオ医薬品の新たな時代を迎える合弁会社設立の決定 アルフレッサ ホールディングスとカイオム・バイオサイエンスが新しい合弁会社を設立し、国内初のバイオシミラーの供給を目指します。

バイオ医薬品の新たな時代を迎える合弁会社設立の決定 #東京都 #中央区 #アルフレッサホールディングス #カイオムバイオサイエンス #Mycenax_Biotech

アルフレッサ ホールディングスとカイオム・バイオサイエンスが新しい合弁会社を設立し、国内初のバイオシミラーの供給を目指します。

Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement Mycenax Biotech Inc. and Japan's RIN Institute have signed a licensing agreement to utilize RIN's proprietary linker technology for ADC development, enhancing therapeutic solutions.

Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement #Taiwan #Taipei #ADC #Mycenax_Biotech #RIN_Institute

Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology Mycenax Biotech has signed a licensing agreement with RIN Institute to utilize its proprietary linker technology. This partnership aims to accelerate ADC development and offers enhanced therapeutic solutions.

Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology #Taiwan #Taipei #ADC_Development #Mycenax_Biotech #RIN_Institute

Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology Mycenax Biotech Inc. and Japan's RIN Institute team up through a license agreement to utilize innovative linker technology for developing advanced ADCs.

Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology #Taiwan #Taipei #ADC_Development #Mycenax_Biotech #RIN_Institute

Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development Mycenax Biotech Inc. and SPERA PHARMA Inc. have joined forces to enhance the production services of antibody-drug conjugates, streamlining development for biopharmaceutical companies.

Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development #Taiwan #Taipei #ADC_Development #SPERA_PHARMA #Mycenax_Biotech

Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services Mycenax Biotech and SPERA PHARMA announce an impactful partnership to enhance the manufacturing of ADC products, optimizing services for biopharmaceutical companies.

Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services #Taiwan #Taipei #ADC_Manufacturing #SPERA_PHARMA #Mycenax_Biotech

Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services Mycenax Biotech Inc. and SPERA PHARMA have partnered to streamline biopharmaceutical manufacturing, focusing on conjugated antibody-drug services.

Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services #Taiwan #Taipei #Pharmaceutical_Manufacturing #SPERA_PHARMA #Mycenax_Biotech